Related Experiment Video
Updated: Sep 20, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
[Transitional Medicine in Epilepsy]
1Division of Neurology, National Center for Child health and Development.
Insights
Neurologists must classify childhood epilepsy by age and cause during transition. Reviewing medication and goals is crucial for refractory cases, especially with comorbidities, requiring physician consultation.
Area of Science:
- Neurology
- Pediatric Neurology
Background:
- Epilepsy treatment requires careful consideration during the transitional period.
- Accurate classification of epilepsy syndromes is essential for effective management.
Purpose of the Study:
- To outline the key considerations for neurologists managing epilepsy during the transitional period.
- To emphasize the importance of syndrome classification, medication review, and collaborative care.
Main Methods:
- Review of current clinical guidelines and best practices for epilepsy management.
- Case-based discussion of challenges in transitional epilepsy care.
Main Results:
- Classification based on age of onset and etiology is critical.
- Review of antiepileptic drugs and treatment goals is necessary for refractory epilepsy.
- Consultation with other physicians is recommended for patients with comorbidities.
Conclusions:
- Effective management of epilepsy in the transitional period necessitates precise syndrome classification.
- Regular review of antiepileptic medication and treatment objectives is vital.
- A multidisciplinary approach involving collaboration with general physicians improves patient outcomes.
Abstract:
When treatment for childhood-onset epilepsy is introduced in the transitional period, neurologists must classify the epilepsy syndrome according to the age of onset and etiology. When a patient with refractory epilepsy consults a neurologist during the transition, it is essential to review the antiepileptic medication and reaffirm the treatment goal. In cases where pre-existing disease or comorbidities are present, a neurologist should treat their patients in consultation with general physicians or home-visit doctors.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

